APA (7th ed.) Citation

Bălaşa, R., Bajko, Z., & Huţanu, A. (2013). Serum levels of IL-17A in patients with relapsing–remitting multiple sclerosis treated with interferon-β. Multiple sclerosis, 19(7), 885-890. https://doi.org/10.1177/1352458512468497

Chicago Style (17th ed.) Citation

Bălaşa, Rodica, Zoltan Bajko, and Adina Huţanu. "Serum Levels of IL-17A in Patients with Relapsing–remitting Multiple Sclerosis Treated with Interferon-β." Multiple Sclerosis 19, no. 7 (2013): 885-890. https://doi.org/10.1177/1352458512468497.

MLA (9th ed.) Citation

Bălaşa, Rodica, et al. "Serum Levels of IL-17A in Patients with Relapsing–remitting Multiple Sclerosis Treated with Interferon-β." Multiple Sclerosis, vol. 19, no. 7, 2013, pp. 885-890, https://doi.org/10.1177/1352458512468497.